Pathology News
FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with...
From the Proscia blog: Concentriq AP v4.11 delivers key updates across image management, pathology experience, and enterprise controls to help labs run faster and smarter. This release builds on Proscia’s recognition as Global 2026...
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI. The suite...
From the Proscia blog From Proscia’s early days, we’ve believed that pathology deserves great technology. As cancer cases grow, the pathologist workforce shrinks, and diagnostic complexity rises, the demands on pathology teams...
Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules, announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification in November of 2025. The RevealDx...
February 2, 2026 at 10:00 a.m. EET. Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is...
